The immunology of stroke: From mechanisms to translation

Nature Medicine

Volumn 17, Issue 7, 2011, Pages 796-808

  Iadecola, Costantino ^a   Anrather, Josef ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ADENOSINE TRIPHOSPHATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CANNABINOID RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; KAINIC ACID; NEUROTRANSMITTER; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTERY OCCLUSION; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; DENDRITIC CELL; ENCEPHALITIS; HELPER CELL; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; MICROGLIA; MOLECULAR LIBRARY; MONOCYTE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE;

ADAPTIVE IMMUNITY; ANTI-INFLAMMATORY AGENTS; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHOCYTES; STROKE;

HARNESS;

EID: 79960141471     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2399     Document Type: Review

References (140)

1. Mena, H., Cadavid, D. & Rushing, E.J. Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol. 108, 524-530 (2004). (Pubitemid 39534594)
2. Moskowitz, M.A., Lo, E.H. & Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198 (2010).
3. Meisel, C., Schwab, J., Prass, K., Meisel, A. & Dirnagl, U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6, 775-786 (2005). (Pubitemid 41679240)
4. Urra, X., Cervera, A., Villamor, N., Planas, A.M. & Chamorro, A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158, 1174-1183 (2009).
5. Weiner, H.L. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann. Neurol. 65, 239-248 (2009).
6. Carden, D.L. & Granger, D.N. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190, 255-266 (2000). (Pubitemid 30141372)
7. Peerschke, E.I., Yin, W. & Ghebrehiwet, B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol. Immunol. 47, 2170-2175 (2010).
8. Pinsky, D.J. et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J. Clin. Invest. 97, 493-500 (1996).
9. Eltzschig, H.K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665 (2011).
10. del Zoppo, G.J., Schmid-Schonbein, G.W., Mori, E., Copeland, B.R. & Chang, C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22, 1276-1283 (1991).
11. Hyman, M.C. et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 119, 1136-1149 (2009).
12. Yilmaz, G. & Granger, D.N. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med. 12, 193-204 (2010).
13. Atochin, D.N. et al. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 117, 1961-1967 (2007). (Pubitemid 47036330)
14. Ishikawa, M., Zhang, J.H., Nanda, A. & Granger, D.N. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front. Biosci. 9, 1339-1347 (2004). (Pubitemid 39060847)
15. Yemisci, M. et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 1031-1037 (2009).
16. Engelhardt, B. & Sorokin, L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 31, 497-511 (2009).
17. Lindsberg, P.J., Strbian, D. & Karjalainen-Lindsberg, M.L. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 30, 689-702 (2010).
18. Strbian, D., Karjalainen-Lindsberg, M.L., Tatlisumak, T. & Lindsberg, P.J. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J. Cereb. Blood Flow Metab. 26, 605-612 (2006).
19. Konsman, J.P., Drukarch, B. & Van Dam, A.M. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin. Sci. (Lond.) 112, 1-25 (2007). (Pubitemid 46127195)
20. Sairanen, T.R., Lindsberg, P.J., Brenner, M. & Siren, A.L. Global forebrain ischemia results in differential cellular expression of interleukin-1 (IL-1) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 17, 1107-1120 (1997). (Pubitemid 27459339)
21. Kono, H. & Rock, K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008). (Pubitemid 351432799)
22. Bours, M.J., Swennen, E.L., Di Virgilio, F., Cronstein, B.N. & Dagnelie, P.C. Adenosine 5 triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358-404 (2006). (Pubitemid 44486409)
23. Melani, A. et al. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem. Int. 47, 442-448 (2005). (Pubitemid 41242625)
24. Schock, S.C. et al. Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance. Brain Res. 1168, 129-138 (2007). (Pubitemid 47320630)
25. Burnstock, G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575-590 (2008). (Pubitemid 351927723)
26. Bune, L.T., Thaning, P., Johansson, P.I., Bochsen, L. & Rosenmeier, J.B. Effects of nucleotides and nucleosides on coagulation. Blood Coagul. Fibrinolysis 21, 436-441 (2010).
27. Pocock, J.M. & Kettenmann, H. Neurotransmitter receptors on microglia. Trends Neurosci. 30, 527-535 (2007). (Pubitemid 47513237)
28. Peachell, P. Regulation of mast cells by agonists. Clin. Rev. Allergy Immunol. 31, 131-142 (2006).
29. Samson, M.T. et al. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J. Immunol. 170, 4953-4962 (2003).
30. Marsh, B.J., Williams-Karnesky, R.L. & Stenzel-Poore, M.P. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 1007-1020 (2009).
31. Hoek, R.M. et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771 (2000).
32. Matsumoto, H. et al. Expression of CD200 by macrophage-like cells in ischemic core of rat brain after transient middle cerebral artery occlusion. Neurosci. Lett. 418, 44-48 (2007). (Pubitemid 46602702)
33. Cardona, A.E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924 (2006). (Pubitemid 43980506)
34. Chapman, G.A. et al. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20, RC87 (2000).
35. Felger, J.C. et al. Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 24, 724-737 (2010).
36. Kostulas, N. et al. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33, 1129-1134 (2002). (Pubitemid 34293602)
37. Gelderblom, M. et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40, 1849-1857 (2009).
38. Yilmaz, A. et al. Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clin. Sci. (Lond.) 118, 147-157 (2009).
39. Hurn, P.D. et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 1798-1805 (2007). (Pubitemid 47624547)
40. Kleinschnitz, C. et al. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115, 3835-3842 (2010).
41. Shichita, T. et al. Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946-950 (2009).
42. Liesz, A. et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199 (2009).
43. Ren, X., Akiyoshi, K., Vandenbark, A.A., Hurn, P.D. & Offner, H. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab. Brain Dis. 26, 87-90 (2010).
44. Becker, K.J. et al. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 94, 10873-10878 (1997). (Pubitemid 27430828)
45. Frenkel, D., et al. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J. Immunol. 171, 6549-6555 (2003). (Pubitemid 37532085)
46. Becker, K., Kindrick, D., McCarron, R., Hallenbeck, J. & Winn, R. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34, 1809-1815 (2003). (Pubitemid 36842650)
47. Becker, K.J. Sensitization and tolerization to brain antigens in stroke. Neuroscience 158, 1090-1097 (2009).
48. Frenkel, D. et al. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 233, 125-132 (2005). (Pubitemid 40804828)
49. Subramanian, S. et al. Recombinant T cell receptor ligand treats experimental stroke. Stroke 40, 2539-2545 (2009).
50. Itakura, A. et al. Characterization of human platelet binding of recombinant T cell receptor ligand. J. Neuroinflammation 7, 75 (2010).
51. Abbas, A.K. Basic Immunology Updated Edition: Functions and Disorders of the Immune System Ch. 5 (Saunders, 2010).
52. Yilmaz, G., Arumugam, T.V., Stokes, K.Y. & Granger, D.N. Role of T lymphocytes and interferon- in ischemic stroke. Circulation 113, 2105-2112 (2006).
53. Offner, H., Vandenbark, A.A. & Hurn, P.D. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 158, 1098-1111 (2009).
54. Andrews, D.M. & Smyth, M.J. A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol. Cell Biol. 88, 107-116 (2010).
55. Spite, M. & Serhan, C.N. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ. Res. 107, 1170-1184 (2010).
56. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882 (2010).
57. Schilling, M. et al. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 196, 290-297 (2005). (Pubitemid 41607817)
58. Denes, A. et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 1941-1953 (2007). (Pubitemid 350129163)
59. Rappert, A. et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 24, 8500-8509 (2004). (Pubitemid 39313773)
60. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758 (2005). (Pubitemid 43085841)
61. Taylor, A., Verhagen, J., Blaser, K., Akdis, M. & Akdis, C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-: the role of T regulatory cells. Immunology 117, 433-442 (2006).
62. Greenberg, D.A. & Jin, K. Growth factors and stroke. NeuroRx 3, 458-465 (2006). (Pubitemid 44443022)
63. Carmichael, S.T. Translating the frontiers of brain repair to treatments: starting not to break the rules. Neurobiol. Dis. 37, 237-242 (2010).
64. Zhang, Z.G., Zhang, L., Jiang, Q. & Chopp, M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90, 284-288 (2002). (Pubitemid 34633929)
65. Hayakawa, K., Qiu, J. & Lo, E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. NY Acad. Sci. 1207, 50-57 (2010).
66. Li, S. et al. An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat. Neurosci. 13, 1496-1504 (2010).
67. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y.C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605 (2007). (Pubitemid 46393607)
68. Hayakawa, K., et al. Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 30, 871-882 (2010).
69. Zhang, Z.G. et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22, 379-392 (2002). (Pubitemid 34273594)
70. Hao, Q., et al. Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J. Cereb. Blood Flow Metab. 27, 1853-1860 (2007). (Pubitemid 47624550)
71. Manoonkitiwongsa, P.S., Schultz, R.L., McCreery, D.B., Whitter, E.F. & Lyden, P.D. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J. Cereb. Blood Flow Metab. 24, 693-702 (2004). (Pubitemid 38725374)
72. Zhang, Z.G. et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838 (2000).
73. Denes, A. et al. Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J. Cereb. Blood Flow Metab. 31, 1036-1050 (2011).
74. Jickling, G.C. et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann. Neurol. 68, 681-692 (2010).
75. Offner, H. et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654-665 (2006).
76. Emsley, H.C.A. et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol. 139, 93-101 (2003). (Pubitemid 36694395)
77. Smith, C.J. et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 4, 2 (2004).
78. Haeusler, K.G. et al. Immune responses after acute ischemic stroke or myocardial infarction. Int. J. Cardiol. published online, doi:10.1016/j.ijcard. 2010.10.053 (13 November 2010).
79. Gendron, A. et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 955, 85-97 (2002). (Pubitemid 35284838)
80. Vogelgesang, A. et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS ONE 5, e8718 (2010).
81. Chamorro, A., Urra, X. & Planas, A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38, 1097-1103 (2007). (Pubitemid 46568484)
82. Prass, K. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725-736 (2003). (Pubitemid 37087772)
83. Leys, D., Henon, H., Mackowiak-Cordoliani, M.A. & Pasquier, F. Poststroke dementia. Lancet Neurol. 4, 752-759 (2005). (Pubitemid 41457291)
84. McColl, B.W., Rothwell, N.J. & Allan, S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 27, 4403-4412 (2007). (Pubitemid 46640725)
85. Becker, K.J., Kindrick, D.L., Lester, M.P., Shea, C. & Ye, Z.C. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J. Cereb. Blood Flow Metab. 25, 1634-1644 (2005). (Pubitemid 41683174)
86. Zierath, D. et al. CNS immune responses following experimental stroke. Neurocrit. Care 12, 274-284 (2010).
87. Fonarow, G.C. et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors and outcomes associated with door-to-needle times within 60 minutes. Circulation 123, 750-758 (2011).
88. Gesuete, R. et al. Recombinant C1 inhibitor in brain ischemic injury. Ann. Neurol. 66, 332-342 (2009).
89. Iadecola, C., Zhang, F. & Xu, X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268, R286-R292 (1995).
90. Lee, S.-T., et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131, 616-629 (2008). (Pubitemid 351294711)
91. Prestigiacomo, C.J. et al. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke 30, 1110-1117 (1999). (Pubitemid 29211635)
92. Stowe, A.M. et al. Neutrophil elastase and neurovascular injury following focal stroke and reperfusion. Neurobiol. Dis. 35, 82-90 (2009).
93. del Zoppo, G.J. Lessons from stroke trials using anti-inflammatory approaches that have failed. in Neuroinflammation in Stroke (eds. Dirnagl, U. & Elger, B.) 155-184 (Springer-Verlagh, Berlin-Heidelberg, 2004).
94. Furuya, K. et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32, 2665-2674 (2001). (Pubitemid 33055322)
95. Fagan, S.C. et al. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 41, 2283-2287 (2010).
96. Jensen, H.A. et al. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 123, 714-721 (2011).
97. Karikó, K., Weissman, D. & Welsh, F.A. Inhibition of Toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24, 1288-1304 (2004). (Pubitemid 39482492)
98. Marsh, B. et al. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839-9849 (2009).
99. Blondeau, N., Widmann, C., Lazdunski, M. & Heurteaux, C. Activation of the nuclear factor-B is a key event in brain tolerance. J. Neurosci. 21, 4668-4677 (2001). (Pubitemid 32565625)
100. Kunz, A. et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 27, 7083-7093 (2007). (Pubitemid 47037566)
101. Ohtsuki, T., Ruetzler, C.A., Tasaki, K. & Hallenbeck, J.M. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 16, 1137-1142 (1996). (Pubitemid 26365364)
102. Pradillo, J.M., et al. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J. Cereb. Blood Flow Metab. 25, 193-203 (2005). (Pubitemid 40171201)
103. Ziv, Y. et al. A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesis. Stroke 38, 774-782 (2007). (Pubitemid 46184258)
104. Steinman, L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13, 139-145 (2007).
105. Schwartz, M., London, A. & Shechter, R. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience 158, 1133-1142 (2009).
106. Genain, C.P. et al. Late complications of immune deviation therapy in a nonhuman primate. Science 274, 2054-2057 (1996). (Pubitemid 27020694)
107. Gee, J.M. et al. Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp. Transl. Stroke Med. 1, 3 (2009).
108. Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821-832 (2010).
109. Kunz, A. et al. Nuclear factor-B activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J. Neurosci. 28, 1649-1658 (2008). (Pubitemid 351287045)
110. Arumugam, T.V., Granger, D.N. & Mattson, M.P. Stroke and T-cells. Neuromolecular Med. 7, 229-242 (2005). (Pubitemid 41507146)
111. Brait, V.H. et al. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes and Nox2-derived superoxide. J. Cereb. Blood Flow Metab. 30, 1306-1317 (2010).
112. Napoli, I. & Neumann, H. Microglial clearance function in health and disease. Neuroscience 158, 1030-1038 (2009).
113. Hanayama, R. et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147-1150 (2004). (Pubitemid 38661849)
114. Buisson, A. et al. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor 1. FASEB J. 12, 1683-1691 (1998). (Pubitemid 28553663)
115. Grilli, M. et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12, 2265-2272 (2000). (Pubitemid 30497024)
116. Arai, K., Jin, G., Navaratna, D. & Lo, E.H. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 276, 4644-4652 (2009).
117. Jauch, E.C. et al. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 37, 2508-2513 (2006). (Pubitemid 44454670)
118. Bornstein, N.M. et al. Antibodies to brain antigens following stroke. Neurology 56, 529-530 (2001). (Pubitemid 32172881)
119. Dambinova, S.A. et al. Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 1752-1762 (2003). (Pubitemid 37194244)
120. Rocklin, R.E., Sheremata, W.A., Feldman, R.G., Kies, M.W. & David, J.R. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervoustissue antigens. N. Engl. J. Med. 284, 803-808 (1971).
121. Gordon, P.H. et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 6, 1045-1053 (2007). (Pubitemid 350116691)
122. Koch, S., Katsnelson, M., Dong, C. & Perez-Pinzon, M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 42, 1387-1391 (2011).
123. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568 (1999). (Pubitemid 29473320)
124. Bacigaluppi, M., Comi, G. & Hermann, D.M. Animal models of ischemic stroke. Part one: modeling risk factors. Open Neurol. J. 4, 26-33 (2010).
125. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 (2010).
126. Bechmann, I. et al. Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur. J. Neurosci. 14, 1651-1658 (2001). (Pubitemid 35478033)
127. Mantovani, A., Sica, A. & Locati, M. Macrophage polarization comes of age. Immunity 23, 344-346 (2005). (Pubitemid 41443435)
128. Rao, K.N. & Brown, M.A. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. NY Acad. Sci. 1143, 83-104 (2008).
129. Borregaard, N. Neutrophils, from marrow to microbes. Immunity 33, 657-670 (2010).
130. Mestas, J. & Hughes, C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738 (2004). (Pubitemid 38263654)
131. Kreisel, D. et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J. Immunol. 169, 6154-6161 (2002). (Pubitemid 36903460)
132. Wan, Y.Y. Multi-tasking of helper T cells. Immunology 130, 166-171 (2010).
133. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P. & Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999). (Pubitemid 29241123)
134. Bonneville, M., O'Brien, R.L. & Born, W.K. T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10, 467-478 (2010).
135. Hayday, A.C. T cells and the lymphoid stress-surveillance response. Immunity 31, 184-196 (2009).
136. Yanamadala, V. & Friedlander, R.M. Complement in neuroprotection and neurodegeneration. Trends Mol. Med. 16, 69-76 (2010).
137. Strasser, A., Jost, P.J. & Nagata, S. The many roles of FAS receptor signaling in the immune system. Immunity 30, 180-192 (2009).
138. Cui, M. et al. Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia. Neurobiol. Dis. 39, 138-147 (2010).
139. Martin-Villalba, A. et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817 (1999). (Pubitemid 29222257)
140. Liesz, A. et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704-720 (2011).